Safety Study of Elotuzumab in Combination With Thalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis C
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus
- Status
- COMPLETED
- Phase
- PHASE2
PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC
- Status
- TERMINATED
- Phase
- PHASE3
Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3
- Status
- COMPLETED
- Phase
- PHASE3
A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-933043 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone
- Status
- WITHDRAWN
- Phase
- PHASE3
Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV
- Status
- TERMINATED
- Phase
- PHASE4
Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients
- Status
- TERMINATED
- Phase
- PHASE2
Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir
- Status
- COMPLETED
- Phase
- PHASE3
Antiviral Efficacy of Switching to ETV Plus TDF
- Status
- UNKNOWN
- Phase
- PHASE4
Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection
- Status
- UNKNOWN
- Phase
- PHASE4
A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China.
- Status
- UNKNOWN
- Phase
- N/A
Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib
- Status
- COMPLETED
- Phase
- PHASE2
An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Single Ascending Dose Safety Study of BMS-962476 in Healthy Subjects and Patients With Elevated Cholesterol on Statins
- Status
- COMPLETED
- Phase
- PHASE1